BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11523074)

  • 1. Sample size recalculation using conditional power.
    Denne JS
    Stat Med; 2001 Sep 15-30; 20(17-18):2645-60. PubMed ID: 11523074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blinded sample size recalculation in clinical trials with binary composite endpoints.
    Sander A; Rauch G; Kieser M
    J Biopharm Stat; 2017; 27(4):705-715. PubMed ID: 27295402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal conditional error functions for the control of conditional power.
    Brannath W; Bauer P
    Biometrics; 2004 Sep; 60(3):715-23. PubMed ID: 15339294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size recalculation in multicenter randomized controlled clinical trials based on noncomparative data.
    Harden M; Friede T
    Biom J; 2020 Sep; 62(5):1284-1299. PubMed ID: 32128868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing the sample size when the unblinded interim result is promising.
    Chen YH; DeMets DL; Lan KK
    Stat Med; 2004 Apr; 23(7):1023-38. PubMed ID: 15057876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reassessment of trial perspectives from interim data--a critical view.
    Bauer P; Koenig F
    Stat Med; 2006 Jan; 25(1):23-36. PubMed ID: 16220517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Operating characteristics of sample size re-estimation with futility stopping based on conditional power.
    Lachin JM
    Stat Med; 2006 Oct; 25(19):3348-65. PubMed ID: 16345019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size adaptation in fixed-dose combination drug trial.
    James Hung HM; Wang SJ
    J Biopharm Stat; 2012; 22(4):679-86. PubMed ID: 22651108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blinded sample size re-estimation in three-arm trials with 'gold standard' design.
    Mütze T; Friede T
    Stat Med; 2017 Oct; 36(23):3636-3653. PubMed ID: 28608469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An internal pilot design for prospective cancer screening trials with unknown disease prevalence.
    Brinton JT; Ringham BM; Glueck DH
    Trials; 2015 Oct; 16():458. PubMed ID: 26463684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A SAS macro for sample size adjustment and randomization test for internal pilot study.
    Wang S; Xia J; Yu L; Li C; Xu L
    Comput Methods Programs Biomed; 2008 Apr; 90(1):66-88. PubMed ID: 18192069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blinded sample size recalculation for clinical trials with normal data and baseline adjusted analysis.
    Friede T; Kieser M
    Pharm Stat; 2011; 10(1):8-13. PubMed ID: 19943322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group sequential and discretized sample size re-estimation designs: a comparison of flexibility.
    Wu X; Cui L
    Stat Med; 2012 Oct; 31(24):2844-57. PubMed ID: 22733405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On sample size estimation and re-estimation adjusting for variability in confirmatory trials.
    Wu PS; Lin M; Chow SC
    J Biopharm Stat; 2016; 26(1):44-54. PubMed ID: 26378970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient adaptive designs with mid-course sample size adjustment in clinical trials.
    Bartroff J; Lai TL
    Stat Med; 2008 May; 27(10):1593-611. PubMed ID: 18275090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of the two-sample t-test statistic following blinded sample size re-estimation.
    Lu K
    Pharm Stat; 2016 May; 15(3):208-15. PubMed ID: 26865383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size reassessment in non-inferiority trials. Internal pilot study designs with ANCOVA.
    Friede T; Kieser M
    Methods Inf Med; 2011; 50(3):237-43. PubMed ID: 20213039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials with nested subgroups: Analysis, sample size determination and internal pilot studies.
    Placzek M; Friede T
    Stat Methods Med Res; 2018 Nov; 27(11):3286-3303. PubMed ID: 29298604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing multiple primary endpoints in clinical trials with sample size adaptation.
    Liu Y; Hu M
    Pharm Stat; 2016; 15(1):37-45. PubMed ID: 26607410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Power and sample size.
    Case LD; Ambrosius WT
    Methods Mol Biol; 2007; 404():377-408. PubMed ID: 18450060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.